Regression of sight-threatening macular edema in type 2 diabetes following treatment with the anti-tumor necrosis factor monoclonal antibody infliximab.
Journal: 2005/May - Diabetes Care
ISSN: 0149-5992
PUBMED: 15677814
Open in
PUBMED | Google Scholar | Wikipedia
Relations:
Citations
(23)
Diseases
(3)
Drugs
(2)
Chemicals
(3)
Organisms
(1)
Affiliates
(1)
Similar articles
Articles by the same authors
Discussion board
Collaboration tool especially designed for Life Science professionals.Drag-and-drop any entity to your messages.